STAT3‐Interacting Proteins as Modulators of Transcription Factor Function: Implications to Targeted Cancer Therapy
Authors:
- 10 December 2015
- journal article
- review article
- Published by Wiley in ChemMedChem
- Vol. 11 (8) , 795-801
Abstract
The oncogenic transcription factor STAT3 is inappropriately activated in multiple hematopoietic and solid malignancies, in which it drives the expression of genes involved in cell proliferation, differentiation, survival, and angiogenesis. Thus far, strategies to inhibit the function of STAT3 have focused on blocking the function of its activating kinases or sequestering its DNA binding ability. A less well‐explored aspect of STAT3 function is its interaction with other proteins, which can modulate the oncogenic activity of STAT3 via its subcellular localization, DNA binding ability, and recruitment of transcriptional machinery. Herein we summarize what is currently known about STAT3‐interacting proteins and describe the utility of a proteomics‐based approach for successfully identifying and characterizing novel STAT3‐interacting proteins that affect STAT3 transcriptional activity and oncogenic function.Keywords
This publication has 84 references indexed in Scilit:
- Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancyNature Genetics, 2013
- Reversible Disruption of mSWI/SNF (BAF) Complexes by the SS18-SSX Oncogenic Fusion in Synovial SarcomaCell, 2013
- Selective inhibition of BET bromodomainsNature, 2010
- A novel small-molecule disrupts Stat3 SH2 domain–phosphotyrosine interactions and Stat3-dependent tumor processesBiochemical Pharmacology, 2010
- A Small-Molecule Inhibitor of BCL6 Kills DLBCL Cells In Vitro and In VivoCancer Cell, 2010
- Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancerCytokine & Growth Factor Reviews, 2010
- The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid TumorsCancer Cell, 2009
- Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in TumorsCancer Cell, 2009
- Inflammation and cancerNature, 2002
- STATs in oncogenesisOncogene, 2000